Mitigation of Indomethacin-Induced Gastric Ulcer in Rats by 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline: Modulation of Inflammatory Mechanisms
DOI:
https://doi.org/10.22317/jcms.v10i4.1582Keywords:
Gastric ulcer, 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline, Indomethacin, inflammatory biomarkers, esomeprazole, ELISA.Abstract
Objective: To investigate the gastroprotective influence of 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline in a rat model of indomethacininduced
gastric ulcers.
Methods: Thirty male Wistar rats were randomly divided into five groups (n = 6) as follows: Group 1 (control), Group 2 (indomethacin only, 30 mg/kg), Group 3 (indomethacin and 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline, 30 mg/kg), Group 4 (indomethacin with 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline, 60 mg/kg), and Group 5 (indomethacin with esomeprazole, 30 mg/kg). The efficacy of 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline in mitigating gastric ulcers induced by indomethacin in rats was evaluated based on gastric morphology, histopathology, and inflammatory biomarkers.
Results: Indomethacin-induced stomach ulcers resulted in epithelial damage and blood streaks on the gastric mucosa. However, treatment
with indomethacin and 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline (60 mg/kg) significantly (P < 0.05) reduced ulcers compared to the indomethacin-only group. Inflammatory cells were observed in the indomethacin group, while the 60 mg/kg 2,3-Dichloro-6- (trifluoromethoxy) quinoxaline-treated group exhibited the restoration of normal epithelial tissue and minimal inflammatory cells, similar to the control and esomeprazole-treated groups. Furthermore, 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline significantly decreased inflammatory biomarkers (TNF-α, IL-6, INF-γ, and IL-β1) and increased gastroprotective mediator levels (PGE2 and mucin), both with P-values below 0.05, in contrast to the effects of indomethacin.
Conclusion: This study provides clinical evidence highlighting the gastroprotective properties of 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline. Its initial application reveals, for the first time, its efficacy in treating gastric ulcers induced by indomethacin. However, further tests are warranted to validate these findings.
References
Abbas, A. M. and Sakr, H. F. (2013) ‘Effect of selenium and grape seed extract on indomethacin-induced gastric ulcers in rats.’ Journal of Physiology and Biochemistry, 69(3) pp. 527–537.
Abbas, H. A. S., Al-Marhabi, A. R. M. and Ammar, Y. A. (2017) ‘Design, synthesis and biological evaluation of 2,3-disubstituted and fused quinoxalines as potential anticancer and antimicrobial agents.’ Acta Poloniae Pharmaceutica - Drug Research, 74(2) pp. 445–458.
Akah, P. A., Orisakwe, O. E., Gamaniel, K. S. and Shittu, A. (1998) ‘Evaluation of Nigerian traditional medicines: II. Effects of some Nigerian folk remedies on peptic ulcer.’ Journal of Ethnopharmacology, 62(2) pp. 123–127.
AlKreathy, H. M., Alghamdi, M. K. and Esmat, A. (2020) ‘Tetramethylpyrazine ameliorates indomethacin-induced gastric ulcer in rats: Impact on oxidative, inflammatory, and angiogenic machineries.’ Saudi Pharmaceutical Journal. The Author(s), 28(8) pp. 916–926.
Altuner, D., Kaya, T. and Suleyman, H. (2020) ‘The protective effect of lercanidipine on indomethacin-induced gastric ulcers in rats.’ Brazilian Archives of Biology and Technology, 63 pp. 1–8.
Bahdailah, A. A. (2019) ‘Basic Knowledge of Non-steroidal Anti-inflammatory Drugs among Saudi Community.’ Pharmacology, Toxicology and Biomedical Reports, 5(2) pp. 93–96.
Bindu, S., Mazumder, S., Dey, S., Pal, C., Goyal, M., Alam, A., Iqbal, M. S., Sarkar, S., Azhar Siddiqui, A., Banerjee, C. and Bandyopadhyay, U. (2013) ‘Nonsteroidal anti-inflammatory drug induces proinflammatory damage in gastric mucosa through NF-κB activation and neutrophil infiltration: Anti-inflammatory role of heme oxygenase-1 against nonsteroidal anti-inflammatory drug.’ Free Radical Biology and Medicine, 65 pp. 456–467.
Boligon, A. A., de Freitas, R. B., de Brum, T. F., Waczuk, E. P., Klimaczewski, C. V., de Ávila, D. S., Athayde, M. L. and de Freitas Bauermann, L. (2014) ‘Antiulcerogenic activity of Scutia buxifolia on gastric ulcers induced by ethanol in rats.’ Acta Pharmaceutica Sinica B, 4(5).
Boushra, A. F., Elsayed, A. M., Ibrahim, N. A., Abdelwahed, M. K. and Ahmed, E. I. (2019) ‘A comparative study on the possible protective effect of esomeprazole, spirulina, wheatgrass on indomethacin-induced gastric ulcer in male albino rats.’ Molecular Biology Reports. Springer Netherlands, 46(5) pp. 4843–4860.
Elfadil, A., Ali, A. S., Alrabia, M. W., Alsamhan, H., Abdulmajed, H., Abu, I. I. M., Allibaih, M. and Ahmed, K. H. B. (2023) ‘The Wound Healing Potential of 2,3 Dimethylquinoxaline Hydrogel in Rat Excisional Wound Model.’ Journal of Pharmaceutical Research International, 35(8) pp. 1–8.
Goldstein, J. L., Hochberg, M. C., Fort, J. G., Zhang, Y., Hwang, C. and Sostek, M. (2010) ‘Clinical trial: The incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone.’ Alimentary Pharmacology and Therapeutics, 32(3) pp. 401–413.
Hawkins, C. and Hanks, G. W. (2000) ‘The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs. A review of the literature.’ Journal of Pain and Symptom Management, 20(2) pp. 140–151.
Kirchner, T., Aparicio, B., Argentieri, D. C., Lau, C. Y. and Ritchie, D. M. (1997) ‘Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.’ Prostaglandins Leukotrienes and Essential Fatty Acids, 56(6) pp. 417–423.
De Lira Mota, K. S., Dias, G. E. N., Pinto, M. E. F., Luiz-Ferreira, Â., Souza-Brito, A. R. M., Hiruma-Lima, C. A., Barbosa-Filho, J. M. and Batista, L. M. (2009) ‘Flavonoids with gastroprotective activity.’ Molecules, 14(3) pp. 979–1012.
MG, R. and SF., L. (2002) ‘Antioxidant properties of natural compounds used in popular medicine for gastric ulcers.’ Brazilian Journal of Medical and Biological Research, 35(May) pp. 523–534.
Musumba, C., Pritchard, D. M. and Pirmohamed, M. (2009) ‘Review article: Cellular and molecular mechanisms of NSAID-induced peptic ulcers.’ Alimentary Pharmacology and Therapeutics.
Pereira, J. A., Pessoa, A. M., Cordeiro, M. N. D. S., Fernandes, R., Prudêncio, C., Noronha, J. P. and Vieira, M. (2015) ‘Quinoxaline, its derivatives and applications: A State of the Art review.’ European Journal of Medicinal Chemistry, 97(1) pp. 664–672.
Saber, T., Ghonaim, M. M., Yousef, A. R., Khalifa, A., Al Qurashi, H., Shaqhan, M. and Samaha, M. (2015) ‘Association of Helicobacter pylori cagA gene with gastric cancer and peptic ulcer in Saudi patients.’ Journal of Microbiology and Biotechnology, 25(7) pp. 1146–1153.
Shaker, E., Mahmoud, H. and Mnaa, S. (2010) ‘Anti-inflammatory and anti-ulcer activity of the extract from Alhagi maurorum (camelthorn).’ Food and Chemical Toxicology, 48(10).
Sowndhararajan, K. and Kang, S. C. (2013) ‘Protective effect of ethyl acetate fraction of Acacia ferruginea DC. against ethanol-induced gastric ulcer in rats.’ Journal of Ethnopharmacology, 148(1) pp. 175–181.
Suleyman, H., Demircan, B., & Karagoz, Y. (2007) ‘Anti-inflammatory and side effects of cyclooxygenase inhibitors.’ Pharmacological Reports, 59(3) pp. 247–258.
Suleyman, H., Albayrak, A., Bilici, M., Cadirci, E. and Halici, Z. (2010) ‘Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers.’ Inflammation, 33(4) pp. 224–234.
Takeuchi, K. and Amagase, K. (2018) ‘Roles of Cyclooxygenase, Prostaglandin E2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract.’ Current Pharmaceutical Design, 24(18) pp. 2002–2011.
Tarnawski, A., Szabo, I. L., Husain, S. S., & Soreghan, B. (2001) ‘Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways.’ Journal of Physiology-Paris, 95(6) pp. 337–344.
Willoughby, D. A., Moore, A. R., & Colville-Nash, P. R. (2000) ‘COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease.’ The Lancet, 355(9204) pp. 646–648.
Yekta, R. F., Amiri-Dashatan, N., Koushki, M., Dadpay, M. and Goshadrou, F. (2019) ‘A metabolomic study to identify potential tissue biomarkers for indomethacin-induced gastric ulcer in rats.’ Avicenna Journal of Medical Biotechnology, 11(4) pp. 299–307.
Zheng, Y. F., Xie, J. H., Xu, Y. F., Liang, Y. Z., Mo, Z. Z., Jiang, W. W., Chen, X. Y., Liu, Y. H., Yu, X. D., Huang, P. and Su, Z. R. (2014) ‘Gastroprotective effect and mechanism of patchouli alcohol against ethanol, indomethacin and stress-induced ulcer in rats.’ Chemico-Biological Interactions, 222.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
